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ABSTRACT: For the ﬁrst time, anisotropic gold nanorods (AuNRs) were embedded
with a photosensitizer dye (crystal violet) in polyurethane (PU) matrix to create the
eﬀective antimicrobial ﬁlm, capable of killing Gram-negative bacteria on its surface
when exposed to white light. The dye, when activated with white light, interacts with
the AuNRs to generate reactive oxygen species (ROS), which kill bacteria. With a
proper control of the aspect ratio (2.1−2.4) and coating of the AuNRs, the ﬁlm can be
tuned to reduce the bacteria population of one to four orders of magnitude (1-log to 4-
log) under 11 klux of light, for an exposure to light between 1 to 3 h. Particularly it
could reduce 104 cfu/cm2 to the level of 1−5 cfu/cm2 in 3 h of light exposure. This
was a desired performance for use on hospital surfaces. In addition, the system showed
antimicrobial eﬀect only when exposed to light, which eliminated the concern for a
cumulative toxic eﬀect on subjects exposed to the material for a long period of time
and limited the time given to the bacteria to develop resistance against the system.
Furthermore, this process of sterilization could be carried out by a commercially available white light lamp, which when in use
did not interrupt the normal routine operation of the environment.
KEYWORDS: antibacterial ﬁlm, sterilization, light activated, nanorods, nanomaterials, noncontact disinfection
1. INTRODUCTION
With the emerging of antibiotic resistant bacteria, the
development and maintenance of sterile environments is
becoming a necessity for hospitals and food manufactures.
The weight of infections caused by multidrug resistant bacteria,
on the US health system, is of 55 billion USD per year,1 and
projections estimate an impact on the world economy for
trillions USD yearly by the 2050.2 Infections from drug
resistant bacteria are often contracted in environments where
bacteria are exposed to drugs with frequent and incomplete
cycles of disinfections, in hospitals or food processing facilities.
The development of hospital acquired infections (HAI)
involves 5% of the intensive care patients in developed
countries (47.9 cases for 1000 hospital hours) and 15.5% of
the patients of the developing countries,3 while cross-
contamination during the handling of food causes a great
number of diseases every year (9.4 million of illnesses and
2612 casualties in the 2011).4 Conventional sterilization
methods are not eﬀective; they require intensive resources
(e.g., chemicals and sterilizing apparatus) and eﬀort from
skilled operators working in the sterile environment.5,6 A
typical hospital surface has 2−5 colonies forming units (cfu)
per cm2 (with peaks of 40−300 cfu/cm2 on ward surfaces or
hospital kitchens) against a tolerant level of <1 cfu/cm2.7,8 A
food preparation plant can have as much as 1000−100 000
cfu/cm2 especially on the preparation tables and abattoir
surfaces,9 which is far from the tolerant level of 500−5000 cfu/
cm2 for meat preparations before cooking and 50 to 500 cfu/
cm2 for minced meat.10 Sterilization based on wiping with
detergents or chemicals is labor intensive and depends
completely on skilled personnel working in the sterile
environment. Tests performed in hospitals around the world
have shown that chemical based routine cleaning is not
thorough enough to achieve the required sterility standards in
more than 40% of the surfaces in close contact with
patients.11−13 To improve the eﬃciency of cleaning processes,
noncontact sterilization methods utilizing reactive gas or UV
light have been introduced. However, these methods have a
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destructive eﬀect on the surfaces and instruments, and their
use is limited to terminal or deep cleaning.14−16 An alternative
approach to reduce contamination without direct intervention
could be the introduction of antimicrobial surfaces. Anti-
microbial surfaces can be based on either materials that slowly
release antimicrobial active substances (proteins, antibiotics, or
heavy metal ions as copper and silver) or in being able to
catalyze the formation of reactive oxygen species (ROS) when
interacting with a source of energy (UV, laser, or white
light).16 Surfaces based on the release of antimicrobial
substances have a good activity in a short period. However,
there are concerns about long-term eﬃciency because the slow
release of antimicrobial substances can trigger the development
of bacterial resistance.16 For light activated antimicrobial ﬁlms,
especially those involving nanomaterials, one of the advantages
is the use of lower intensity light radiation to activate the
antimicrobial eﬀect compared to the use of light alone. One
example of this kind of surfaces is composed of a silicon matrix
containing TiO2 nanoparticles.
17 The presence of nano-
particles reduces the time of exposure required to kill bacteria
but still requires UV light to be activated, which limits the
access to the sterilized area. More recently, hybrid systems
based on metal nanoparticles, particularly small spherical gold
nanoparticles (<5 nm, AuNPs), and a sensitizer dye have been
introduced. This nanoparticle based catalysis of ROS shows a
great antimicrobial activity under the exposure to laser light in
the visible range.18,19 In a normal white light condition, it
requires as long as 6 h to reach to comparable level of activity
as that using laser light. Moreover, this system has certain
toxicity in the dark that may limit its application.20 In the past
decade, anisotropic metal nanoparticles, as gold nanorods
(AuNRs), have attracted interest for medical applications due
to their strong localized electromagnetic ﬁeld and intense
plasmonic properties;21 however, they were never been used
for antimicrobial surfaces. The antibacterial ﬁlm proposed in
this work uses AuNRs as an energy collector to increase the
quantity of ROS generated by a photosensitizer dye,
throughout plasmonic coupling. The introduction of rod-
shaped gold nanoparticles of suitable aspect ratio (2.1−2.4)
and UV−visible absorption range, according to the photo-
sensitizer dye’s absorption spectrum, increases/steps up the
activity of the system when exposed to white neon light. The
energy absorbed by the ﬁlm led to the production of ROS,22
which are able to damage the bacteria attached to the ﬁlm
surface. In contrast to the traditional methods of sterilization
that rely on the application of chemical substances (70%
ethanol, hydrogen peroxide, peracetic acid, chlorine releasing
agents, acid and basic solutions)23,24 or the use of sterilizing
apparatus (autoclaves, UV chamber, ionizing radiations, high
temperature dry sterilization),25 this system maintains a
continuous antimicrobial eﬀect, and it is powered by merely
exposure to a commercially available white light lamp without
any direct intervention. This attribute makes this ﬁlm an
innovative way of reducing the risk of developing resistant
bacterial strains due to an incomplete cleaning process,26 while
being nontoxic when not exposed to light, thus limiting the
time given to the bacteria to develop resistance.27
2. MATERIALS AND METHODS
2.1. Reagents. Hexadecyltrimethylamonium bromide (CTAB, ≥
98%) was purchased from Tokyo Chemical Industry. Hydrogen
tetrachloroaurate solution (HAuCl4, 30 wt %), sodium borohydride
(NaBH4, ≥ 98%), silver nitrate (AgNO3, ≥ 99.0%), sodium bromide
(NaBr, ≥ 99,99%), L-ascorbic acid (C6H8O6, ≥ 99%), poly(sodium 4-
styrenesulfonate) (NaPSS, Mw 70 kDa), sodium citrate (citNa, >
99%), thiol-polyethylene glycol-carboxylic acid (thiol-PEG, > 99%),
sodium chloride (≥ 99%), sodium ﬂuorescein (ﬂuorescent tracer
grade), and sodium hydroxide (NaOH, ≥ 97%) were obtained from
Sigma-Aldrich, Singapore. H2O2 solution (30−32 wt %) was acquired
from QüreC (Quality Reagents Chemical, New Zealand), while
hydrochloric acid (HCl, 36−38 wt %, Duskan Pure Chemical) was
acquired from Duskan Reagents, Singapore. Polyurethane (1 mm
thick, Swees Engineering Co., pte, PU) and crystal violet (≥ 99%,
Certistain, CV) were obtained from MERK, Singapore; Nutrient Agar
(NA) CM0003 was obtained from Oxoid).
2.2. Gold Nanorods Preparation. Gold nanorods (AuNRs)
were prepared using a modiﬁed seed mediated synthesis
approach.28−30 Surfactant micelles (CTAB) were used as template
to grow nanorods from seeds formed in a diﬀerent solution.31 The
surfactant was then removed, and the resulting AuNRs were stabilized
by either citNa or thiol-PEG. Details procedures are described below.
The seeds solution was prepared by mixing 5 mL of an aqueous
solution of 0.5 mM HAuCl4 with 5 mL of 0.2 M CTAB and reduced
with 0.6 mL of an ice cold 10 mM NaBH4 solution. After the reaction,
the solution was left to incubate for 1 h to allow the Ostwald ripening
to focus the size and shape of the seeds formed.32 The growth
solution was prepared by adding 75 μL of 10 mM AgNO3 to a 5 mL
of a solution 0.2 M of CTAB and later adding 5 mL of 1.4 mM
HAuCl4, followed by 0.25 mL of 1.25 M NaBr. When all the
components were added to the batch, it was left incubating for at least
15 min and then reduced with 105 μL of 79 mM L-ascorbic acid. After
30 s of agitation, 60 μL of seeds solution was added to trigger the
formation of the rods. The solution was left incubating for 12 h at 30
°C to complete the growth process. After the synthesis, the particles
were stabilized by a bilayer of cationic surfactant (CTAB), which was
the main component of the growth solution. This surfactant is
strongly toxic against bacteria and human tissues (liver and heart),
while gold nanorods stabilized with nontoxic capping agents (e.g.,
PEG or sodium citrate) are widely considered biocompatible.33 The
surfactant was removed from the surface of the particles with cycles of
centrifugation (14 000 rpm, 10 min using Mikro 220R Hettich
centrifuge).34 The resulting concentrated suspension of gold nano-
rods was redispersed in microﬁltered deionized water, followed by
two cycles of centrifugation (14 000 rpm, 7 min) and ﬁnally
redispersed in a solution of poly(sodium 4-styrenesulfonate)
(PSSNa) 0.15% w/w, which acted as a temporary capping agent to
remove the CTAB strongly attached to the surface of the rods.34 After
the last cycle of CTAB removal with PSSNa, the surface of the
particles was modiﬁed with sodium citrate, using an extra cycle of
centrifugation a redispersion with a solution of 10 mM citNa,
followed by an overnight incubation. Alternatively, a solution of thiol-
PEG-carboxylic acid (thiol-PEG) 50 μg/mL was used to modify the
surface of the AuNRs to provide stabilization. The absorption spectra
of the particles dispersions were acquired using a Biotek Synergy 2,
plate reader, while the size and aspect ratio of the nanorods in a batch
were determined using ImageJ software35 on a collection of at least 10
TEM image, each containing from 50−300 particles. All the images
were acquired using a Philips CM300 FEG TEM operating at 300 kV.
2.3. Preparation of Antimicrobial Film and Study of CV−
AuNRs Interaction. The preparation of the polyurethane/AuNRs/
crystal violet (PU/AuNRs/CV) ﬁlm began by embedding the AuNRs
into PU. The AuNRs were loaded on the PU ﬁlm using the swelling-
encapsulation-shrink method.20 The PU ﬁlm was exposed to a
solution containing 90% of acetone and 10% of the AuNRs colloidal
solution (optical density 1.5, approximately 0.127 mg/mL) to obtain
an approximated concentration of 0.345 mM of [Au0] absorbed on 30
cm2 of PU ﬁlm. After overnight incubation, the samples were washed
with deionized water, and the remaining acetone was evaporated from
the ﬁlm until the polymer was shrunk to the original dimension. The
CV dye was then absorbed on the AuNRs embedded PU ﬁlm by
diﬀusion incubating 1 cm2 tiles of the modiﬁed polymer in a solution
of 1 mM crystal violet for 48 h (approximated concentration in the
polymer 0.325 mM). The resulting ﬁlm is denoted as PU/AuNRs/CV
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ﬁlm. The interaction in solution between CV dye and AuNRs
stabilized with the two diﬀerent methods was performed by measuring
the UV−vis absorption of 10 μM of CV containing 20% v/v of
AuNRs (≈ 30 μM), after 30 s of vortex agitation.
2.4. Antimicrobial Activity Test and ROS Production
Quantiﬁcation. The antimicrobial activity of the AuNRs embedded
PU impregnated with CV (PU/AuNRs/CV) ﬁlm was tested in a
humid environment, where 1 cm2 of the ﬁlm was inoculated with 25
μL of bacterial dispersion (E. coli ATC25922, 108 cfu/mL), to have a
starting point of 2.5 × 106 cfu. The source of light used for the tests
was a 28 W Wattmiser GE lamp, a high eﬃciency neon lamp
commonly diﬀused in Europeans hospital and commercial buildings.
The samples were tested in triplicate and covered with microscope
coverslip to preserve the samples humidity during the time of light
exposure. After the exposure period, the tiles of polymer and the
coverslips were introduced in a 50 mL centrifuge tube and vortexed
with 2 mL of 0.9% NaCl solution to collect all the surviving bacteria.
The solution obtained was aliquoted on nutrient agar plates and
incubated for an overnight at 37 °C with controlled humidity in a
Binder incubator (Red Line). During the incubation time, every living
bacteria plated on nutrient agar formed visible colonies that were
counted to calculate the eﬃciency of system.36 The ﬁlm samples were
tested for activity in diﬀerent exposure times (1, 1.5, 2, and 3 h) and
per activity at diﬀerent illumination intensities (8.7, 9.4, and 11.7
klux) at 2 and 3 h time points.
To conﬁrm the mechanism of the antimicrobial eﬀect, the
production of ROS in the system was calculated using a modiﬁed
version of the oxygen radical absorbance capability (ORAC) assay37,38
by measuring the variation of ﬂuorescence intensity of a 0.5 μg/mL
ﬂuorescein solution,39 alkalinized with 50 μL of 1 M NaOH, when
exposed for 1 h to 11.7 klux of white light using the same set up used
for the antimicrobial experiments. The photobleaching rate of a
ﬂuorescein solution in alkaline condition was constant and reported in
literature;40,41 thus, the diﬀerence of ﬂuorescence between the
solutions exposed to light on the surface of unmodiﬁed PU or on
PU/CV and PU/citNa-AuNRs/CV could be used to determine the
amount of ROS produced using the Stern−Volmer39 equation and
conﬁrmed using a calibration with aliquots of 1, 5, 7.5, 10, and 12.5
mM H2O2 on the ﬂuorescein solution exposed to light for 1 h on PU.
All the ﬂuorescence intensity measurements were performed with a
Biotek plate reader with excitation ﬁlter 485/20, emission ﬁlter 580/
20, gain 70, and mirror position 635 nm. The main emission peak of
ﬂuorescein was located at 515 nm, and the ﬂuorescence intensity was
measured with a ﬁlter at 580 ± 20 nm on the tail of the peak to avoid
the interference of the excitation wavelength (calibration curve in the
SI, Figure S1). The importance of the radical production for the
eﬃciency of the system was conﬁrmed adding 20 mM of L-ascorbic
acid at pH 7 to the solution containing the bacteria (0.9% NaCl in
water). In the experiment, L-ascorbic acid acted as an antioxidant to
scavenge the ROS generated by the system42 and thus reduce the
number of bacteria killed by the ﬁlm.
3. RESULTS AND DISCUSSION
We have reasoned that the activity of the ﬁlm derives from the
interaction between the excited state of the crystal violet (CV)
dye and the AuNRs both encapsulated in the PU ﬁlm. AuNRs
have a broad absorption spectrum and greater absorption
coeﬃcient compared to organic dyes43 and thus higher
capability to concentrate the energy absorbed in a localized
electrical ﬁeld.29 If the AuNRs are dispersed in a ﬂuid, the fast-
changing electrical ﬁeld releases the energy absorbed on the
environment under the hyperthermal eﬀect.44 While, when
they are embedded in the polymer matrix, this route of energy
relaxation is not available because the particles are conﬁned. In
this condition, the presence of dye molecules in close
proximity to the particles induced a strong plasmonic coupling
between dye and AuNRs, thanks to the overlapping of their
absorption spectra due to the bespoke short rods, which greatly
increased the amount of energy absorbed by the dye45,46 and
consequently increased the amount of ROS generated and the
antimicrobial eﬀect generated by the ﬁlm (Figure 1).47
To understand if the antibacterial action of the ﬁlm has a
component of hyperthermia, the temperature changes of the
polymer exposed to light have been tracked with a
thermocouple. Results show no measurable variation between
the unmodiﬁed PU and for the PU/citNa-AuNRs/CV ﬁlm
(temperature measurements for 2 h experiment in the SI,
Figure S2). To complete our exploration of the system, we
have conducted systematic characterization to the ﬁlm and a
comprehensive study of the interactions between CV dye and
AuNRs with desired aspect ratio and surface coating before
testing their antibacterial action. Details are given in the
following sections.
3.1. Gold Nanorods Characterization. To match the
CV’s absorption for eﬃcient energy transfer, AuNRs with an
intense longitudinal LSPR peak at 650 nm, Figure 1, have been
synthesized. The particles after the synthesis were immersed in
a concentrated solution of CTAB; this surfactant was necessary
for the synthesis, but it was positively charged and toxic. The
removal process, explained in the Materials and Methods
section, managed a complete exchange of the CTAB surfactant
with PSSNa, which was negatively charged. PSSNa weakly
absorbs on the surface of the particles and could easily be
replaced by nontoxic stabilizer, that is, sodium citrate (citNa,
negatively charged) or thiol-PEG (weak negative charge). The
exchange of CTAB with citNa or thiol-PEG blue-shifted the
lateral surface plasmon resonance peak of the particles by 10
nm due to the change of the refractive index of the solution
and the density of charges in surrounding medium of the
particles, Figure 2.48
The dimensions of the particles were obtained analyzing
TEM pictures: 20 to 30 nm length (L) and of 7 to 14 nm
diameter (D), resulting in an average aspect ratio of 2.1 ± 0.3
L/D. The TEM images were taken after the elimination of
CTAB because the surfactant forms crystals during the
preparation of the samples, which interfere with the quality
of the pictures. The TEM characterization of the size and
aspect ratio of the gold nanorods has been performed on
particles stabilized by citrate (Figure 3). Citrate stabilization
gives to the AuNRs a shelf life 2 months if stored at 4 °C.
Figure 1. Overview of the photochemical mechanism of ROS
generation for CV and CV/AuNRs ﬁlms.
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3.2. Study of CV Interaction with AuNRs. To aﬃrm our
hypothesis that the antimicrobial action of the system relied on
the interaction of CV dye with the AuNRs in the polymer
matrix, their interactions (both with the thiol-PEG and citNa
stabilized AuNRs) in solution have been studied by measuring
the UV−vis spectrum of the mixture of AuNRs with CV,
Figure 4.
Thiol-PEG is a very eﬀective steric stabilizer due to its large
molecular weight (3500 Da); when used to stabilize gold
nanoparticles, it formed a thick polymeric coating with a weak
negative charge.49 CitNa instead have a smaller molecular
weight (189.1 Da) and a strong negative charge,50 forming a
thin charged layer on the surface of the particles. This
diﬀerence of stabilizer thickness and surface charge inﬂuenced
the interactions between AuNRs and dye, as shown from the
changes in the absorption spectra of the two mixed samples.
The CV molecules (positively charged) had a signature peak at
590 nm and a shoulder peak at 580 nm. When mixed with
AuNRs, a signiﬁcant peak at 520 nm was observed for the
citNa-coated AuNRs, and similar, but less intense, for the thiol-
PEG coated one. These peaks can be seen in the spectra of the
mixed solution and from subtraction of the spectra of 10 μM
CV and 30 μM nanorods solutions in the SI, Figure S3. The
AuNRs shown in Figure 4d were stabilized with citNa; the
particles stabilized in the two methods had similar spectra for
very low concentrations (spectra reported in the Supporting
Information Figure S3). Since the citNa coating was composed
of a thin layer of small molecules (MW of citNa is 189.1 Da),
the strong electrostatic interaction between CV and citNa
allowed CV molecules to come close enough to the AuNRs
surface, which improved the coupling eﬀect between the SPR
of the particles and the dye, which generated an eﬃcient
absorption enhancement of the peak at 520 nm.45,46,51 It is
worth noticing that both spectra of mixed solutions containing
AuNRs either coated with citNa or thiol-PEG show a strong
reduction of the CV peak at 590 nm wavelength, suggesting
the presence of a strong plasmonic and electronic interaction
between the dye and the nanorods. In addition to the
conﬁrmation of CV-AuNRs interactions, especially in the
citNa-AuNRs, the comparison of the spectra between 660 and
700 nm shows that in solution AuNRs aggregate in the
presence of CV molecules. The degree of aggregation
(broadening of the peak at that wavelength range) was more
evident for citNa coated AuNRs than thiol-PEG coated
AuNRs. This could be an additional evidence of CV−nanorods
interaction because CV neutralize the surface charge and thus
removal of electrostatic protection in citNa-coated AuNRs.
This aggregation in solution is however a not a concern for the
eﬃciency of the antibacterial system because the nanoparticles
and the dye were added to the polymeric matrix with two
diﬀerent processes, trapping the nanorods inside the PU ﬁlm
with swelling/shrinking method and later diﬀusing the dye into
the polymer.
3.3. PU/AuNRs/CV Film Characterization. The embed-
ment of AuNRs in the polyurethane polymer was conﬁrmed by
comparing the UV−visible spectra of the polymer before
(Figure 5A(a)) and after embedding the AuNRs (Figure
5A(b)). By subtracting the two spectra, it was possible to see
that the characteristic peaks of the AuNRs at 520 and 640 nm
(Figure 5A(c)) were maintained, signaling that AuNRs were
not aggregated.
As showed in Figure 5B, CV maintain the characteristic two
peaks structure after the diﬀusion in the polymer (Figure
5B(d)). When the polymer contained both AuNRs and dye,
Figure 2. UV−visible spectra of AuNRs (a) in the presence of CTAB;
(b) after CTAB removal and substitution with thiol-poly ethylene
glycol-carboxylic acid; or (c) substitution with sodium citrate.
Figure 3. TEM analysis of the cit-AuNRs: (A) TEM picture at
25 000× magniﬁcations; (B) TEM picture at 39 600× magniﬁcations;
(C) distribution of aspect ratios; and (D) size distribution.
Figure 4. UV−visible spectra of (a) CV 10 μM, (b) citNa coated
AuNRs in the presence of 10 μM CV, (c) thiol-PEG-AuNRs in the
presence of 10 μM CV, (d) 20% (≈ 30 μM) citNa coated AuNRs.
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the peak intensity of the dye absorption decreased (Figure
5B(e)) as previously seen for the samples in solution (Figure
4b). AuNRs alone in the polymer showed an increase of the
absorption at shorter wavelength; this eﬀect is also shown in
the full complex (Figure 5B(e)). This variation of the
absorption shows how the optical properties of the dyes and
the AuNRs were inﬂuenced by their interactions within the
conﬁned space of the polymeric matrix. This could be that
diﬀerent energy absorptions became more accessible. The
intensity of the AuNRs peaks detected in the polymer
increased linearly with the increase of concentration used in
the swelling/encapsulation/shrink process, which conﬁrmed
the reproducibility of the embedding process (Figure S4).
For the preparation of the samples used in this work, an
AuNRs dispersion of 1.5 O.D. had been used (ﬁnal
concentration in the polymer 0.345 mM) because higher
concentrations caused saturation and did not improve the
performance of the ﬁlm. The subsequent step in the ﬁlm
preparation was the diﬀusion of CV in the polymer; to
determine the optimal time needed for the process, the amount
of CV diﬀused in the PU/AuNRs ﬁlm over a range of 0−90 h
of incubation time was measured using UV−visible absorption
spectra. It was found that, for the ﬁxed CV concentration of 1
mM, near solubility concentration, the amount of dye diﬀused
in the polymer increased linearly for the ﬁrst 8 h and settled to
a slow increase until 30 h, where the progression reached a
plateau (Figure S5, Supporting Information). The ideal
diﬀusion time for the samples used in the article was set to
48 h, equivalent to an approximated concentration in the
polymer of 0.325 mM; for a ratio dye/nanorods of
approximately 1:1, the penetration of the dye in the polymeric
matrix was visible to naked eyes and uniform for all the
thickness of the ﬁlm.
3.4. Quantiﬁcation of ROS Production. Control tests
with identical set up to the antimicrobial testing, Figure 6, were
performed on a solution of ﬂuorescein 0.5 μg/mL alkalinized
with NaOH 5 mM to conﬁrm the hypothesis that the
antimicrobial action was attributable to the generation of
ROS52 and to quantify the eﬀect of the nanorods on their
production.
Fluorescein in alkaline environment produced a strong
ﬂuorescence emission at 520 nm (absorption 480 nm), which
was progressively quenched when exposed to light and more
rapidly reduced after the interaction with oxygen reactive
species.37 The magnitude of the reduction of ﬂuorescence
intensity, for a quenching process driven by the interaction
between ﬂuorescein and a quencher in solution, was modeled
by the Stern−Volmer equation for a bimolecular quenching
driven by diﬀusion:39
τ= + [ ]I
I
k Q1 q
0
0
Where I0 was the ﬂuorescence of a ﬂuorescein solution exposed
to light for 1 h on the surface of unmodiﬁed polymer, I was the
ﬂuorescence intensity of the solution exposed to light for 1 h
on the surface of a polymer modiﬁed with CV or CV and
citNa-AuNRs, τ0 was the ﬂuorescence decay in absence of a
quencher at 25 °C (3.60 ns), kq was the bimolecular quenching
rate constant at 25 °C (7.64 × 109 M−1 s−1), and [Q] was the
concentration of the quencher. The calculation shows a ROS
production of 3.03 ± 0.60 mM per hour for the PU/CV ﬁlm
and 5.26 ± 0.02 mM for the PU/citNa-AuNRs/CV ﬁlm. To
conﬁrm the ROS production, experimental results were
obtained from a calibration curve measuring the ﬂuorescence
of the ﬂuorescein solution after exposure to light for 1 h on
unmodiﬁed polymer and simulating the production of ROS
with aliquots of H2O2 and incubating in the dark overnight
(Figure S1, Supporting Information). The ROS concentration
measured with the calibration curve showed comparable results
Figure 5. (A) UV−visible spectra of (a) PU, (b) PU/citNa-AuNRs
ﬁlm. (c) Subtraction curve (b−a); (B) UV−visible spectra of (d) PU/
CV and (e) PU/citNa-AuNRs/CV. All data have been normalized to
compensate the diﬀraction of the polymeric ﬁlm.
Figure 6. Scheme of the antibacterial ﬁlm testing procedure: (A) PU/
AuNRs/CV ﬁlm samples are supported on a slide over some
bidistilled water to prevent dehydration; (B) after the inoculation with
bacteria cells, the samples are protected with glass coverslips; (C) ﬁlm
samples and coverslips are washed with NaCl 0.9% to recover the
remaining bacteria if any; (D) bacteria solution is serially diluted and
plated on nutrient agar and (E) the colony formed are counted.
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with the theory, but it introduced some variability due the
increased amount of experimental procedure required to
obtain the results (2.24 ± 1.94 mM for polymer and CV,
5.32 ± 2.65 mM for the sample containing CV and AuNRs).
The agreement between the results obtained theoretically and
from the calibration with hydrogen peroxide suggested that the
main radical species generated by the ﬁlm is the hydroxyl
radical, which is the most favorite product of the decom-
position of H2O2 in the condition of the experiment.
53 The
importance of the production of ROS for the action of the
system has been further conﬁrmed by adding L-ascorbic acid
20 mM buﬀered at pH 7 to the bacteria dispersion, which,
being an antioxidant, had the ability to quench the amount of
ROS released by the ﬁlm. With the introduction of 20 mM L-
ascorbic acid to the system, the activity of the ﬁlm was indeed
reduced by approximately 15-times.
3.5. Antibacterial Tests. As discussed earlier, citNa
stabilized AuNRs can interact with CV eﬀectively through
electrostatic interaction. Thus, the polymeric ﬁlm embedded
with citNa AuNRs (PU/citNA-AuNRs/CV) was tested against
E. coli (starting concentration 2.5 × 108) for 1 h, 1.5 h, 2 h, and
3 h of 11.7 klux of light exposure and for 2 and 3 h of exposure
to diﬀerent light intensities. To conﬁrm the activity of the
antimicrobial ﬁlm, controls of PU alone, PU modiﬁed with
AuNRs, and modiﬁed with CV alone were tested for the
antibacterial action under same amount of light exposure and
time. Results showed that in the ﬁrst hour of the exposure, the
bacteria on the PU/citNa-AuNRs/CV polymer sample were
reduced of an order of magnitude (1-log reduction). By
extending the time exposure to 1.5, 2, and 3 h, the population
of bacteria decreased exponentially to 2-log, 3-log, and 3.5−4-
log, respectively (3 h was the longest time tested) (Figure
7d,e).
This rate of antibacterial activity, 4-log in 3 h, is particularly
interesting against gram (−) bacteria, which possess a double
layer bacterial membrane and they are generally resistant to
this kind of sterilization.20 Our results were a signiﬁcant
improvement compared to the results reported in literature for
spherical Au nanoparticles, which needed much longer of light
exposure (6 h). The control ﬁlms, which were tested
separately, retained only a limited eﬃciency, with activity
reduced of orders of magnitude compared with the full
complex. For example, the controls containing only polymer
and citNa-AuNRs (without CV) had barely any eﬀect on the
bacteria population until the 3 h time point (reduced by 1-log
only), while the PU/CV sample maintained a fraction of the
activity, reducing the bacteria population of less of an order of
magnitude after 2 h and 1.25−1.5-log after 3 h. The
importance of the AuNRs-CV interaction (or CV binding to
AuNRs) for an eﬀective antibacterial action was aﬃrmed by
the experiment using thiol-PEG modiﬁed AuNRs. The PU/
thiol-PEG-AuNRs/CV ﬁlm had only a small antibacterial
activity (no reduction of bacterial count after 2 h exposure, and
merely 0.5-log reduction after 3 h light exposure, p < 0.0001).
As discussed earlier, gold nanorods with thiol-PEG coating had
a weak negative charge, which hindered the interaction with
the positively charged CV dye, as shown from the interaction
in solution in Figure 4. To understand the relation between the
intensity of the light and the speed of the bacterial reduction,
the antimicrobial ﬁlm (PU/citNA-AuNRs/CV) was subse-
quently tested for 2 and 3 h action with reduced intensity of
illumination from 11.7 klux to 9.4 klux and 8.7 klux. The
system was also tested in the absence of light to check the
chemical toxicity of the modiﬁed polymeric ﬁlm (Figure
8B(a)).
Results showed that the same ﬁlm samples kept in the dark
did not possess any intrinsic toxicity, (Figure 8B(a)), which
conﬁrmed that light−ﬁlm interaction was pivotal for bacteria
reduction. Furthermore, the degree of bacteria reduction was
dependent on the level of illumination; reducing the light given
to the ﬁlm to produce ROS slowed down their production and
consequently the bacteria killings. Speciﬁcally, the eﬃciency of
the system increased exponentially with the increase of light
intensity and the time of the exposure (Figure 8B(b−d)). The
light intensity dependency of the ﬁlm action was consistent for
both the 2 and 3 h exposure time points (Figure 8A). This
means that given a certain amount of time it would be possible
to estimate the bacterial reduction according to the intensity of
the light and the time needed to reach a complete kill of the
bacteria. In a normal working condition, the ﬁlm will not be
constantly exposed to 8 to 11.7 klux of light intensity but
would be exposed to a more usual lighting intensity of
approximately 1 klux, in which the production of ROS for the
ﬁlm was not detectable. Higher light intensity would only be
applied during a routine sterilization process or during
operations that need constant sterility as a surgical procedure.
Limiting the activated period of the ﬁlm to short period greatly
reduced the risk for the bacteria to develop bacteria resistance.
In literature, similar antimicrobial ﬁlms could resist to a month
of continuous light exposure;20 limiting the exposure of the
ﬁlm to high intensity light will extend the life of the ﬁlm to
months of use.
With the optimal design of the polymer ﬁlm, embedded with
anisotropic AuNRs of appropriate aspect ratio and a proper
surface coating which facilitates interaction with the CV dye,
our ﬁlm provides eﬃcient antibacterial action under white
light. It did not depend on specialized sources of light, for
example, UV lamps and lasers, and showed no toxic eﬀects
when not activated.
Figure 7. Antibacterial eﬀect against E. coli of 2.5 × 106 at starting
count. Remaining bacteria count with (a) PU polymer alone, (b)
polymer with citNa-AuNRs, (c) polymer with CV, and (d) full
complex PU/citNa-AuNRs/CV ﬁlm measured at diﬀerent light
exposure time of 1, 1.5, 2, and 3 h. (e) Fitting for the rate of
bacteria elimination for the PU/citNa-AuNRs/CV ﬁlm. ∗ p < 0.05, ∗∗
p < 0.01, ∗∗∗ p < 0.001.
ACS Applied Bio Materials Article
DOI: 10.1021/acsabm.9b00343
ACS Appl. Bio Mater. 2019, 2, 3059−3067
3064
4. CONCLUSION
We reported a novel nanoplasmonic based antibacterial
polymer ﬁlm. It consisted of anisotropic AuNRs and an
organic dye capable of generating ROS. The principle of action
of this ﬁlm was based on the plasmonic coupling interaction of
AuNRs and the nearby dye both conﬁned in a polymer ﬁlm
under normal lighting, which allow for eﬀective generation of
ROS in quantiﬁable amounts. This antibacterial ﬁlm oﬀered a
vital alternative for continuous background bacterial reduction
without requiring the active use of chemicals or the use of
energetic radiations and thus allowing the continuation of the
operation in the sterile environment during the sterilization.
The ﬁlm was able to reduce the number of Gram-negative
bacteria on its surface from a concentration of 104 cfu/cm2 to
the level of 1−5 cfu/cm2, acceptable for a hospital surface after
3 h of light exposure. For the ﬁrst time, it was demonstrated
that the produced ﬁlm could kill Gram-negative bacteria, which
are more diﬃcult to eradicate. The low toxicity when not
exposed to light and the practicality of having an antimicrobial
device embedded on a solid-state polymeric ﬁlm makes it a
promising candidate for future applications and a practical
solution for the problem of maintaining sterility in environ-
ments in contact with the public and to further reduce the
pandemic diﬀusion of antimicrobial drug resistance.
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